ScopeUniversity Hospitals Birmingham NHS Foundation Trust
85 capabilities
Verified Oct 2026
One of 2,018 in United Kingdom
Send one structured enquiry and we chase the reply for you. No cold email, no chasing.
Details
Queen Elizabeth Hospital Birmingham, Haematology and Transfusion Department, Mindelsohn Way, Edgbaston
Edgbaston B15 2WB , United Kingdom
Edgbaston B15 2WB , United Kingdom
Accreditation
Active
UKAS
8784
uhb.nhs.uk
Prefer to enquire through us? Send an enquiry
Accreditation Details
Accreditation Body
UKAS
Number
8784
Status
ActiveAccreditation is granted under EU Regulation 765/2008 and assessed against ISO/IEC 17025. Data sourced from official UKAS records.
Download Scope PDF
Test Capabilities (85)
| Standard Reference | Description | Category |
|---|---|---|
| ANTI Xa | Anti-Xa | Clinical Chemistry |
| Fibrinogen | Fibrinogen | Clinical Chemistry |
| G6PD (Quantitative) assay measurement | G6PD (Quantitative) assay measurement | Clinical Chemistry |
| INR | INR | Clinical Chemistry |
| PT | Prothrombin Time (PT) | Clinical Chemistry |
| Prothrombin Time | Prothrombin Time | Clinical Chemistry |
| Thromboplastin Time | Thromboplastin time | Clinical Chemistry |
| Malaria Parasite detection and speciation | Malaria Parasite detection and speciation | Clinical Microbiology |
| Malarial antigens for: Plasmodium falciparum and pan-detection for: Plasmodium malariae, Plasmodium ovale & Plasmodium vivax | Malarial antigens for: Plasmodium falciparum and pan-detection for: Plasmodium malariae, Plasmodium ovale & Plasmodium vivax | Clinical Microbiology |
| P. knowlesi measurement | P. knowlesi measurement | Clinical Microbiology |
| MEASUREMENT | Measurement | Electrical |
| ABO and RhD groups | ABO and RhD groups | Hematology |
| ABO/RhD Blood Group | ABO/RhD Blood Group | Hematology |
| ADAMTS_13 activity | ADAMTS_13 activity | Hematology |
| ADAMTS_13 inhibitor | ADAMTS_13 inhibitor | Hematology |
| Activated Partial | Activated Partial | Hematology |
| Anti-D, C, E, c, e, Cw, K, k, Kp(a), Kp(b), Fy(a), Fy(b), Jk(a), Jk(b), Le(a), Le(b), P1, M, N, S, s, Lu(a) and Lu(b) | Anti-D, C, E, c, e, Cw, K, k, Kp(a), Kp(b), Fy(a), Fy(b), Jk(a), Jk(b), Le(a), Le(b), P1, M, N, S, s, Lu(a) and Lu(b) | Hematology |
| Antibody Screening | Antibody Screening | Hematology |
| Blood Film - preparation for confirmation of FBC results, manual differential if applicable, white, red and platelet number assessment and morphology | Blood Film - preparation for confirmation of FBC results, manual differential if applicable, white, red and platelet number assessment and morphology | Hematology |
| Coagulation examination activities for the purposes of clinical diagnosis | Coagulation examination activities for the purposes of clinical diagnosis: APTT (Activated Partial Thromboplastin time) D-Dimer Factor VIII Inhibitor screen Factor VIII, IX, XI Fibrinogen (Clauss) Thrombin time measurement | Hematology |
| Compatibility testing between donor red cell antigens and patient plasma antibodies | Compatibility testing between donor red cell antigens and patient plasma antibodies | Hematology |
| Crossmatch - serological compatibility testing between donor red cell antigens and patient plasma antibody | Crossmatch - serological compatibility testing between donor red cell antigens and patient plasma antibody | Hematology |
| Detection and Estimation of Foetal Maternal Haemorrhage measurement | Detection and Estimation of Foetal Maternal Haemorrhage measurement | Hematology |
| Direct Antiglobulin Test | Direct Antiglobulin Test: detection of | Manual technique using BioRad | Hematology |
| Direct Antiglobulin Test measurement | Direct Antiglobulin Test measurement | Hematology |
| Erythrocyte Sedimentation | Erythrocyte Sedimentation | Hematology |
| Haematocrit (HCT) | Haematocrit (HCT) | Hematology |
| Haematology examination activities for the purposes of clinical diagnosis | Haematology examination activities for the purposes of clinical diagnosis: Blood Count- Full blood count (Red blood cells, White blood cells, Hb, MCH, MCHC, MCV, HCT, Neutrophils, Lymphocytes, Monocytes, Basophils, Eosinophils, Platelets) Reticulocytes Nucleated Cell count Morphology- Blood film assessment | Hematology |
| Haemoglobinopathy screen to confirm or exclude presence of haemoglobin variant and / or thalassaemia | Haemoglobinopathy screen to confirm or exclude presence of haemoglobin variant and / or thalassaemia | Hematology |
| Haemoglobinuria | Haemoglobinuria | Hematology |
| Hb variant confirmation | Hb variant confirmation | Hematology |
| Identification of Red Cell anti- D, C, E, c, e, Cw, K, k, Kp(a),Kp(b), Fy(a), Fy(b), Jk(a), Jk(b), Le(a), Le(b), P1, M, N, S, s, Lu(a) and Lu(b) | Identification of Red Cell anti- D, C, E, c, e, Cw, K, k, Kp(a),Kp(b), Fy(a), Fy(b), Jk(a), Jk(b), Le(a), Le(b), P1, M, N, S, s, Lu(a) and Lu(b) | Hematology |
| Immature Platelet Fraction (IPF) | Immature Platelet Fraction (IPF) | Hematology |
| Includes the following parameters: Haemoglobin (HGB) | Includes the following parameters: Haemoglobin (HGB) | Hematology |
| Lupus Anticoagulant | Lupus anticoagulant | Hematology |
| Mean Platelet Volume(MPV) (A only) | Mean Platelet Volume(MPV) (A only) | Hematology |
| PTT, aPTT with 50% NP | PTT, aPTT with 50% NP | Hematology |
| Plasma Viscosity | Plasma Viscosity | Hematology |
| Platelet Count (PLT) | Platelet count (PLT) | Hematology |
| Platelet distribution width (PDW) | Platelet distribution width (PDW) | Hematology |
| Prothrombin (Factor II), Factor V, VII, IX, X, XI, XII | Prothrombin (Factor II), Factor V, VII, IX, X, XI, XII | Hematology |
| Rapid group forward group with anti-A, anti-B and anti-D | Rapid group forward group with anti-A, anti-B and anti-D | Hematology |
| Red Blood Cell Count (RBC) | Red Blood Cell count (RBC) | Hematology |
| Red Cell Distribution | Red Cell Distribution | Hematology |
| Red Cell Phenotyping | Red cell phenotyping: Jka, Jkb, Fya, Fyb, M, N, S, s | Hematology |
| Sickle Solubility test for presence of sickle haemoglobin (HbS) | Sickle solubility test for presence of sickle haemoglobin (HbS) | Hematology |
| Thrombin Time | Thrombin Time | Hematology |
| Thrombocytopenia (HIT) | Thrombocytopenia (HIT) | Hematology |
| Transfusion examination activities for the purposes of clinical diagnosis | Transfusion examination activities for the purposes of clinical diagnosis: A,B,O, AB and RhD+/- Baby/Cord blood Blood group | Hematology |
| White Blood Cell Count (WBC) | White Blood Cell Count (WBC) | Hematology |
| Width(RDW) | Width(RDW) | Hematology |
| Free Protein S Antigen | Free Protein S Antigen | Immunology / Serology |
| VWF | VWF:AC | Immunology / Serology |
| Molecular (Haematology) examination activities for the purposes of clinical diagnosis: Factor V Leiden (FVL) | Molecular (Haematology) examination activities for the purposes of clinical diagnosis: Factor V Leiden (FVL) | Molecular Diagnostics / PCR |
| Prothrombin gene (G20210A) measurement | Prothrombin gene (G20210A) measurement | Molecular Diagnostics / PCR |
| Activity pre treatment, post treatment | Activity pre treatment, post treatment | Other |
| Antithrombin function | Antithrombin function | Other |
| Apixaban (A) | Apixaban (A) | Other |
| Collagen Binding Assay (CBA) | Collagen Binding Assay (CBA) | Other |
| Detection of Antigens | Detection of antigens | Other |
| Edoxaban (B only) | Edoxaban (B only) | Other |
| Emicizumab Assay | Emicizumab Assay | Other |
| Enzyme panel, Indirect Antiglobulin Test panel Identification of antibodies: Anti-D, C, E, c, e, Cw, K, k, Kp(a), Kp(b), Fy(a), Fy(b), Jk(a), Jk(b), Le(a), Le(b), P1, M, N, S, s, Lu(a) and Lu(b) | Enzyme panel, Indirect Antiglobulin Test panel Identification of antibodies: Anti-D, C, E, c, e, Cw, K, k, Kp(a), Kp(b), Fy(a), Fy(b), Jk(a), Jk(b), Le(a), Le(b), P1, M, N, S, s, Lu(a) and Lu(b) | Other |
| F.IX pre treatment, post treatment | F.IX pre treatment, post treatment | Other |
| F.VIII inhibitor (H) | F.VIII inhibitor (H) | Other |
| F.VIII pre treatment, post treatment | F.VIII pre treatment, post treatment | Other |
| FACTOR VIII | Factor VIII | Other |
| Fondaparinux (Arixtra) (A Only) | Fondaparinux (Arixtra) (A Only) | Other |
| Heparin Induced | Heparin Induced | Other |
| Heparin(LMWH) (A & B only) | Heparin(LMWH) (A & B only) | Other |
| Inhibitor Screen measurement | Inhibitor Screen measurement | Other |
| Low Molecular Weight | Low molecular weight | Other |
| P malariae | P malariae | Other |
| P. Ovale | P. ovale | Other |
| P. Vivax | P. vivax | Other |
| P. falciparum | P. falciparum | Other |
| PT with 50% NP | PT with 50% NP | Other |
| Paroxysmal Nocturnal | Paroxysmal Nocturnal | Other |
| Phenotype of antigens | Phenotype of antigens | Other |
| Protein C function | Protein C function | Other |
| Rate | Rate | Other |
| Rivaroxaban (A) | Rivaroxaban (A) | Other |
| Screening of antibodies | Screening of antibodies | Other |
| D Dimer | D-Dimer | Spectroscopy (XRF, ICP, AAS) |
| HBA1C | HbA1c | Spectroscopy (XRF, ICP, AAS) |
Send an Enquiry
Request a quote, ask about capacity, or discuss your testing requirements directly with this lab.